Sandy H Fang

Assistant Professor

20042019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Sandy H Fang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Anus Neoplasms Medicine & Life Sciences
Colectomy Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Databases Medicine & Life Sciences
Quality Improvement Medicine & Life Sciences
Ulcerative Colitis Medicine & Life Sciences
Rectal Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

Colectomy
Ulcerative Colitis
Emergencies
Quality Improvement
Mortality
Rectal Neoplasms
Survival
Neoplasms
Quality of Health Care
Survival Analysis

Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma

Jia, A. Y., Narang, A., Safar, B., Zaheer, A., Murphy, A., Azad, N., Gearhart, S. L., Fang, S. H., Efron, J., Warczynski, T., Hacker-Prietz, A. & Meyer, J., Aug 19 2019, In : Radiation Oncology. 14, 1, 147.

Research output: Contribution to journalArticle

Open Access
Neoadjuvant Therapy
Adenocarcinoma
Radiotherapy
Drug Therapy
oxaliplatin

The Impact of Imatinib on Survival and Treatment Trends for Small Bowel and Colorectal Gastrointestinal Stromal Tumors

Almaazmi, H., Stem, M., Lo, B. D., Taylor, J. P., Fang, S. H., Safar, B., Efron, J. & Atallah, C., Jan 1 2019, (Accepted/In press) In : Journal of Gastrointestinal Surgery.

Research output: Contribution to journalArticle

Gastrointestinal Stromal Tumors
Colorectal Neoplasms
Survival
Therapeutics
Imatinib Mesylate

Treatment Strategies and Survival Trends for Anorectal Melanoma: Is it Time for a Change?

Taylor, J. P., Stem, M., Yu, D., Chen, S. Y., Fang, S. H., Gearhart, S. L., Safar, B. & Efron, J., Jan 1 2019, In : World journal of surgery.

Research output: Contribution to journalArticle

Immunotherapy
Melanoma
Survival
Therapeutics
Medicare